CAS 804518-63-6
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
10 produits trouvés.
2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl
CAS :Formule :C24H33N5O4SDegré de pureté :99%Couleur et forme :SolidMasse moléculaire :487.6149Ref: IN-DA00GAHY
5mgÀ demander10mgÀ demander250mgÀ demander25mg180,00€50mg222,00€1mg359,00€100mg526,00€2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
CAS :2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-oneFormule :C24H33N5O4SDegré de pureté :98%Masse moléculaire :487.63Yonkenafil-d8
CAS :Formule :C24H25D8N5O4SCouleur et forme :Pale Yellow SolidMasse moléculaire :495.67Yonkenafil-d7
CAS :Formule :C24H26D7N5O4SCouleur et forme :Pale Yellow SolidMasse moléculaire :494.66Yonkenafil
CAS :Yonkenafil is a potent, selective inhibitor of the enzyme cGMP-specific phosphodiesterase type 5 (PDE5). It is used for the treatment of erectile dysfunction. Yonkenafil has been shown to inhibit nitric oxide synthase (NOS) activity, which may be responsible for its neuroprotective effect. This compound also inhibits microglia activation and neuronal death in vitro and in vivo. Yonkenafil has been shown to be effective in the treatment of Parkinson's disease symptoms, such as cognitive impairment and motor deficits.Formule :C24H33N5O4SDegré de pureté :Min. 95%Masse moléculaire :487.6 g/molYonkenafil
CAS :Yonkenafil (Tunodafil) is a PDE5 inhibitor that improves neurological outcomes and cognitive function in models.Formule :C24H33N5O4SDegré de pureté :99.99%Couleur et forme :Yellow SolidMasse moléculaire :487.61
